{"id":26484,"date":"2025-07-08T10:44:59","date_gmt":"2025-07-08T08:44:59","guid":{"rendered":"https:\/\/www.chemsafe-consulting.com\/?p=26484"},"modified":"2025-07-08T10:48:46","modified_gmt":"2025-07-08T08:48:46","slug":"breaking-barriers-including-pregnant-and-breastfeeding-individuals-in-clinical-trials","status":"publish","type":"post","link":"https:\/\/www.chemsafe-consulting.com\/it\/blog\/breaking-barriers-including-pregnant-and-breastfeeding-individuals-in-clinical-trials\/","title":{"rendered":"Breaking Barriers: Including Pregnant and Breastfeeding Individuals in Clinical Trials"},"content":{"rendered":"<p>Clinical trials have long shaped the future of medicine. But for decades, one vital population has remained mostly sidelined: <strong>pregnant and breastfeeding individuals<\/strong>. Now, that\u2019s changing.<\/p>\n<p>With the release of the <strong>ICH E21 Draft Guideline<\/strong>, global health regulators have taken a bold step to encourage the safe, ethical, and proactive inclusion of pregnant and breastfeeding people in clinical research. This guideline, now under public consultation, marks a significant move toward equity, scientific rigor, and public health protection.<\/p>\n<p>&nbsp;<\/p>\n<h4><strong>Why This Guideline Matters<\/strong><\/h4>\n<p>Millions of people who are pregnant or breastfeeding manage chronic and acute conditions \u2014 from autoimmune disorders to infections and mental health issues. Yet, they are often excluded from drug trials, leading to a lack of evidence to guide treatment during these critical life stages.<\/p>\n<p>Without this data:<\/p>\n<ul>\n<li>Healthcare providers may avoid essential treatments.<\/li>\n<li>Patients may receive inappropriate dosing.<\/li>\n<li>Breastfeeding might be discouraged due to unknown risks.<\/li>\n<li>Harmful or ineffective treatments may be used unknowingly.<\/li>\n<\/ul>\n<p>The ICH E21 guideline aims to fix this evidence gap with structured, science-backed recommendations.<\/p>\n<p>&nbsp;<\/p>\n<h4><strong>Key Goals of the ICH E21 Guideline<\/strong><\/h4>\n<ul>\n<li><strong>Inclusion by Design<\/strong>: Clinical trial planning should account for the needs of pregnant and breastfeeding populations from early development through post-approval.<\/li>\n<li><strong>Risk-Benefit Evaluation<\/strong>: Inclusion should be based on a &#8220;weight-of-evidence&#8221; approach \u2014 combining nonclinical data, safety profiles, and potential benefits.<\/li>\n<li><strong>Flexible Consent and Safety<\/strong>: Trials must ensure informed consent and minimize risks to both the individual and their baby.<\/li>\n<li><strong>Real-World Data Use<\/strong>: Post-marketing surveillance and real-world evidence are vital to understanding long-term effects and rare outcomes.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h4><strong>What\u2019s New for Pregnancy in Clinical Trials?<\/strong><\/h4>\n<p>The guideline emphasizes that <strong>pregnancy is not a contraindication by default<\/strong>. Instead, the decision to include pregnant individuals should be:<\/p>\n<ul>\n<li>Driven by medical need.<\/li>\n<li>Informed by nonclinical (animal) studies and early human data.<\/li>\n<li>Based on the product\u2019s potential impact during different trimesters.<\/li>\n<\/ul>\n<p>Sponsors are encouraged to plan for:<\/p>\n<ul>\n<li>Tailored study designs (e.g., PK\/PD studies during pregnancy).<\/li>\n<li>Risk mitigation strategies.<\/li>\n<li>Tracking fetal exposure and neonatal outcomes.<\/li>\n<\/ul>\n<p>Importantly, if a participant becomes pregnant during a trial, there should be options for continued participation with proper safeguards and re-consent.<\/p>\n<p>&nbsp;<\/p>\n<h4><strong>Considerations for Breastfeeding Individuals<\/strong><\/h4>\n<p>The guideline outlines a structured approach:<\/p>\n<ol>\n<li><strong>Assess drug transfer into breast milk.<\/strong><\/li>\n<li><strong>Estimate infant exposure and potential risks.<\/strong><\/li>\n<li><strong>Evaluate the impact on breastfeeding itself (e.g., milk production).<\/strong><\/li>\n<\/ol>\n<p>Breastfeeding participants may be included if:<\/p>\n<ul>\n<li>The investigational product poses minimal risk to the infant.<\/li>\n<li>The infant may also benefit from exposure (e.g., immune conditions).<\/li>\n<\/ul>\n<p>Protocols should allow flexibility \u2014 such as pumping and discarding milk \u2014 and provide lactation support to help participants continue breastfeeding safely.<\/p>\n<p><em>\u00a0<\/em><\/p>\n<h4><strong>Ethical and Practical Challenges<\/strong><\/h4>\n<p>Including these populations raises complex ethical and logistical challenges. The guideline addresses:<\/p>\n<ul>\n<li>The importance of IRBs\/Ethics Committees with relevant expertise.<\/li>\n<li>Strategies for respectful and culturally sensitive recruitment.<\/li>\n<li>Minimizing procedural burdens (e.g., virtual visits, aligned check-ups).<\/li>\n<li>Clear communication of potential risks and benefits.<\/li>\n<\/ul>\n<p>&nbsp;<\/p>\n<h4><strong>What This Means for the Future<\/strong><\/h4>\n<p>This guideline represents a cultural shift in research \u2014 one that recognizes the autonomy, needs, and rights of pregnant and breastfeeding people. By fostering their inclusion, the scientific community can close longstanding knowledge gaps, ensure safer treatments, and better protect both parents and children.<\/p>\n<p>&nbsp;<\/p>\n<h4><strong>Get Involved<\/strong><\/h4>\n<p>The ICH E21 Guideline is currently open for public consultation until <strong>15 September 2025<\/strong>. Researchers, healthcare professionals, patients, and advocates are encouraged to review and submit feedback to help shape its final form.<\/p>\n<p>&nbsp;<\/p>\n<p><strong><a href=\"https:\/\/www.ema.europa.eu\/en\/news\/new-guideline-inclusion-pregnant-breastfeeding-individuals-clinical-trials\">Sources<\/a><\/strong><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Clinical trials have long shaped the future of medicine. But for decades, one vital population has remained mostly sidelined: pregnant and breastfeeding individuals. Now, that\u2019s changing. With the release of the ICH E21 Draft Guideline, global health regulators have taken a bold step to encourage the safe, ethical, and proactive inclusion of pregnant and breastfeeding people in clinical research. This guideline, now under public consultation, marks a significant move toward equity, scientific rigor, and public health protection. &nbsp; Why This Guideline Matters Millions of people who are pregnant or breastfeeding manage chronic and acute conditions \u2014 from autoimmune disorders to infections and mental health issues. Yet, they are often excluded from drug trials, leading to a lack of evidence to guide treatment during these critical life stages. Without this data: Healthcare providers may avoid essential treatments. Patients may receive inappropriate dosing. Breastfeeding might be discouraged due to unknown risks. Harmful or ineffective treatments may be used unknowingly. The ICH E21 guideline aims to fix this evidence gap with structured, science-backed recommendations. &nbsp; Key Goals of the ICH E21 Guideline Inclusion by Design: Clinical trial planning should account for the needs of pregnant and breastfeeding populations from early development through post-approval&#8230;.<\/p>\n","protected":false},"author":2,"featured_media":26485,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[53,66],"tags":[],"class_list":["post-26484","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-blog","category-pharma"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v26.6 (Yoast SEO v26.6) - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Breaking Barriers: Including Pregnant and Breastfeeding Individuals in Clinical Trials - ChemSafe<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.chemsafe-consulting.com\/it\/blog\/breaking-barriers-including-pregnant-and-breastfeeding-individuals-in-clinical-trials\/\" \/>\n<meta property=\"og:locale\" content=\"it_IT\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Breaking Barriers: Including Pregnant and Breastfeeding Individuals in Clinical Trials\" \/>\n<meta property=\"og:description\" content=\"Clinical trials have long shaped the future of medicine. But for decades, one vital population has remained mostly sidelined: pregnant and breastfeeding individuals. Now, that\u2019s changing. With the release of the ICH E21 Draft Guideline, global health regulators have taken a bold step to encourage the safe, ethical, and proactive inclusion of pregnant and breastfeeding people in clinical research. This guideline, now under public consultation, marks a significant move toward equity, scientific rigor, and public health protection. &nbsp; Why This Guideline Matters Millions of people who are pregnant or breastfeeding manage chronic and acute conditions \u2014 from autoimmune disorders to infections and mental health issues. Yet, they are often excluded from drug trials, leading to a lack of evidence to guide treatment during these critical life stages. Without this data: Healthcare providers may avoid essential treatments. Patients may receive inappropriate dosing. Breastfeeding might be discouraged due to unknown risks. Harmful or ineffective treatments may be used unknowingly. The ICH E21 guideline aims to fix this evidence gap with structured, science-backed recommendations. &nbsp; Key Goals of the ICH E21 Guideline Inclusion by Design: Clinical trial planning should account for the needs of pregnant and breastfeeding populations from early development through post-approval....\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.chemsafe-consulting.com\/it\/blog\/breaking-barriers-including-pregnant-and-breastfeeding-individuals-in-clinical-trials\/\" \/>\n<meta property=\"og:site_name\" content=\"ChemSafe\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-08T08:44:59+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-07-08T08:48:46+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.chemsafe-consulting.com\/wp-content\/uploads\/2025\/07\/Pregnant-Woman.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1280\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Gabriele Pincitore\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Scritto da\" \/>\n\t<meta name=\"twitter:data1\" content=\"Gabriele Pincitore\" \/>\n\t<meta name=\"twitter:label2\" content=\"Tempo di lettura stimato\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minuti\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.chemsafe-consulting.com\/it\/blog\/breaking-barriers-including-pregnant-and-breastfeeding-individuals-in-clinical-trials\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.chemsafe-consulting.com\/it\/blog\/breaking-barriers-including-pregnant-and-breastfeeding-individuals-in-clinical-trials\/\"},\"author\":{\"name\":\"Gabriele Pincitore\",\"@id\":\"https:\/\/www.chemsafe-consulting.com\/it\/#\/schema\/person\/ef0ec20da44f19fd3ed5eb9334b54119\"},\"headline\":\"Breaking Barriers: Including Pregnant and Breastfeeding Individuals in Clinical Trials\",\"datePublished\":\"2025-07-08T08:44:59+00:00\",\"dateModified\":\"2025-07-08T08:48:46+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.chemsafe-consulting.com\/it\/blog\/breaking-barriers-including-pregnant-and-breastfeeding-individuals-in-clinical-trials\/\"},\"wordCount\":575,\"publisher\":{\"@id\":\"https:\/\/www.chemsafe-consulting.com\/it\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.chemsafe-consulting.com\/it\/blog\/breaking-barriers-including-pregnant-and-breastfeeding-individuals-in-clinical-trials\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.chemsafe-consulting.com\/wp-content\/uploads\/2025\/07\/Pregnant-Woman.png\",\"articleSection\":[\"Blog\",\"Pharma\"],\"inLanguage\":\"it-IT\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.chemsafe-consulting.com\/it\/blog\/breaking-barriers-including-pregnant-and-breastfeeding-individuals-in-clinical-trials\/\",\"url\":\"https:\/\/www.chemsafe-consulting.com\/it\/blog\/breaking-barriers-including-pregnant-and-breastfeeding-individuals-in-clinical-trials\/\",\"name\":\"Breaking Barriers: Including Pregnant and Breastfeeding Individuals in Clinical Trials - ChemSafe\",\"isPartOf\":{\"@id\":\"https:\/\/www.chemsafe-consulting.com\/it\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.chemsafe-consulting.com\/it\/blog\/breaking-barriers-including-pregnant-and-breastfeeding-individuals-in-clinical-trials\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.chemsafe-consulting.com\/it\/blog\/breaking-barriers-including-pregnant-and-breastfeeding-individuals-in-clinical-trials\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.chemsafe-consulting.com\/wp-content\/uploads\/2025\/07\/Pregnant-Woman.png\",\"datePublished\":\"2025-07-08T08:44:59+00:00\",\"dateModified\":\"2025-07-08T08:48:46+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/www.chemsafe-consulting.com\/it\/blog\/breaking-barriers-including-pregnant-and-breastfeeding-individuals-in-clinical-trials\/#breadcrumb\"},\"inLanguage\":\"it-IT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.chemsafe-consulting.com\/it\/blog\/breaking-barriers-including-pregnant-and-breastfeeding-individuals-in-clinical-trials\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\/\/www.chemsafe-consulting.com\/it\/blog\/breaking-barriers-including-pregnant-and-breastfeeding-individuals-in-clinical-trials\/#primaryimage\",\"url\":\"https:\/\/www.chemsafe-consulting.com\/wp-content\/uploads\/2025\/07\/Pregnant-Woman.png\",\"contentUrl\":\"https:\/\/www.chemsafe-consulting.com\/wp-content\/uploads\/2025\/07\/Pregnant-Woman.png\",\"width\":1280,\"height\":1024},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.chemsafe-consulting.com\/it\/blog\/breaking-barriers-including-pregnant-and-breastfeeding-individuals-in-clinical-trials\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.chemsafe-consulting.com\/it\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Breaking Barriers: Including Pregnant and Breastfeeding Individuals in Clinical Trials\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.chemsafe-consulting.com\/it\/#website\",\"url\":\"https:\/\/www.chemsafe-consulting.com\/it\/\",\"name\":\"ChemSafe\",\"description\":\"Your lighthouse in a sea of rules\",\"publisher\":{\"@id\":\"https:\/\/www.chemsafe-consulting.com\/it\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.chemsafe-consulting.com\/it\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"it-IT\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.chemsafe-consulting.com\/it\/#organization\",\"name\":\"ChemSafe\",\"url\":\"https:\/\/www.chemsafe-consulting.com\/it\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\/\/www.chemsafe-consulting.com\/it\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.chemsafe-consulting.com\/wp-content\/uploads\/2023\/09\/logo-blu.png\",\"contentUrl\":\"https:\/\/www.chemsafe-consulting.com\/wp-content\/uploads\/2023\/09\/logo-blu.png\",\"width\":170,\"height\":69,\"caption\":\"ChemSafe\"},\"image\":{\"@id\":\"https:\/\/www.chemsafe-consulting.com\/it\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.linkedin.com\/company\/chemsafe-srl\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.chemsafe-consulting.com\/it\/#\/schema\/person\/ef0ec20da44f19fd3ed5eb9334b54119\",\"name\":\"Gabriele Pincitore\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"it-IT\",\"@id\":\"https:\/\/www.chemsafe-consulting.com\/it\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/fcfc5334bd73000515e017fd70f0559c45e85a8c514b7ebdccbfc77232c63d67?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/fcfc5334bd73000515e017fd70f0559c45e85a8c514b7ebdccbfc77232c63d67?s=96&d=mm&r=g\",\"caption\":\"Gabriele Pincitore\"},\"url\":\"https:\/\/www.chemsafe-consulting.com\/it\/author\/chemsafe\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Breaking Barriers: Including Pregnant and Breastfeeding Individuals in Clinical Trials - ChemSafe","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.chemsafe-consulting.com\/it\/blog\/breaking-barriers-including-pregnant-and-breastfeeding-individuals-in-clinical-trials\/","og_locale":"it_IT","og_type":"article","og_title":"Breaking Barriers: Including Pregnant and Breastfeeding Individuals in Clinical Trials","og_description":"Clinical trials have long shaped the future of medicine. But for decades, one vital population has remained mostly sidelined: pregnant and breastfeeding individuals. Now, that\u2019s changing. With the release of the ICH E21 Draft Guideline, global health regulators have taken a bold step to encourage the safe, ethical, and proactive inclusion of pregnant and breastfeeding people in clinical research. This guideline, now under public consultation, marks a significant move toward equity, scientific rigor, and public health protection. &nbsp; Why This Guideline Matters Millions of people who are pregnant or breastfeeding manage chronic and acute conditions \u2014 from autoimmune disorders to infections and mental health issues. Yet, they are often excluded from drug trials, leading to a lack of evidence to guide treatment during these critical life stages. Without this data: Healthcare providers may avoid essential treatments. Patients may receive inappropriate dosing. Breastfeeding might be discouraged due to unknown risks. Harmful or ineffective treatments may be used unknowingly. The ICH E21 guideline aims to fix this evidence gap with structured, science-backed recommendations. &nbsp; Key Goals of the ICH E21 Guideline Inclusion by Design: Clinical trial planning should account for the needs of pregnant and breastfeeding populations from early development through post-approval....","og_url":"https:\/\/www.chemsafe-consulting.com\/it\/blog\/breaking-barriers-including-pregnant-and-breastfeeding-individuals-in-clinical-trials\/","og_site_name":"ChemSafe","article_published_time":"2025-07-08T08:44:59+00:00","article_modified_time":"2025-07-08T08:48:46+00:00","og_image":[{"width":1280,"height":1024,"url":"https:\/\/www.chemsafe-consulting.com\/wp-content\/uploads\/2025\/07\/Pregnant-Woman.png","type":"image\/png"}],"author":"Gabriele Pincitore","twitter_card":"summary_large_image","twitter_misc":{"Scritto da":"Gabriele Pincitore","Tempo di lettura stimato":"3 minuti"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.chemsafe-consulting.com\/it\/blog\/breaking-barriers-including-pregnant-and-breastfeeding-individuals-in-clinical-trials\/#article","isPartOf":{"@id":"https:\/\/www.chemsafe-consulting.com\/it\/blog\/breaking-barriers-including-pregnant-and-breastfeeding-individuals-in-clinical-trials\/"},"author":{"name":"Gabriele Pincitore","@id":"https:\/\/www.chemsafe-consulting.com\/it\/#\/schema\/person\/ef0ec20da44f19fd3ed5eb9334b54119"},"headline":"Breaking Barriers: Including Pregnant and Breastfeeding Individuals in Clinical Trials","datePublished":"2025-07-08T08:44:59+00:00","dateModified":"2025-07-08T08:48:46+00:00","mainEntityOfPage":{"@id":"https:\/\/www.chemsafe-consulting.com\/it\/blog\/breaking-barriers-including-pregnant-and-breastfeeding-individuals-in-clinical-trials\/"},"wordCount":575,"publisher":{"@id":"https:\/\/www.chemsafe-consulting.com\/it\/#organization"},"image":{"@id":"https:\/\/www.chemsafe-consulting.com\/it\/blog\/breaking-barriers-including-pregnant-and-breastfeeding-individuals-in-clinical-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/www.chemsafe-consulting.com\/wp-content\/uploads\/2025\/07\/Pregnant-Woman.png","articleSection":["Blog","Pharma"],"inLanguage":"it-IT"},{"@type":"WebPage","@id":"https:\/\/www.chemsafe-consulting.com\/it\/blog\/breaking-barriers-including-pregnant-and-breastfeeding-individuals-in-clinical-trials\/","url":"https:\/\/www.chemsafe-consulting.com\/it\/blog\/breaking-barriers-including-pregnant-and-breastfeeding-individuals-in-clinical-trials\/","name":"Breaking Barriers: Including Pregnant and Breastfeeding Individuals in Clinical Trials - ChemSafe","isPartOf":{"@id":"https:\/\/www.chemsafe-consulting.com\/it\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.chemsafe-consulting.com\/it\/blog\/breaking-barriers-including-pregnant-and-breastfeeding-individuals-in-clinical-trials\/#primaryimage"},"image":{"@id":"https:\/\/www.chemsafe-consulting.com\/it\/blog\/breaking-barriers-including-pregnant-and-breastfeeding-individuals-in-clinical-trials\/#primaryimage"},"thumbnailUrl":"https:\/\/www.chemsafe-consulting.com\/wp-content\/uploads\/2025\/07\/Pregnant-Woman.png","datePublished":"2025-07-08T08:44:59+00:00","dateModified":"2025-07-08T08:48:46+00:00","breadcrumb":{"@id":"https:\/\/www.chemsafe-consulting.com\/it\/blog\/breaking-barriers-including-pregnant-and-breastfeeding-individuals-in-clinical-trials\/#breadcrumb"},"inLanguage":"it-IT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.chemsafe-consulting.com\/it\/blog\/breaking-barriers-including-pregnant-and-breastfeeding-individuals-in-clinical-trials\/"]}]},{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/www.chemsafe-consulting.com\/it\/blog\/breaking-barriers-including-pregnant-and-breastfeeding-individuals-in-clinical-trials\/#primaryimage","url":"https:\/\/www.chemsafe-consulting.com\/wp-content\/uploads\/2025\/07\/Pregnant-Woman.png","contentUrl":"https:\/\/www.chemsafe-consulting.com\/wp-content\/uploads\/2025\/07\/Pregnant-Woman.png","width":1280,"height":1024},{"@type":"BreadcrumbList","@id":"https:\/\/www.chemsafe-consulting.com\/it\/blog\/breaking-barriers-including-pregnant-and-breastfeeding-individuals-in-clinical-trials\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.chemsafe-consulting.com\/it\/"},{"@type":"ListItem","position":2,"name":"Breaking Barriers: Including Pregnant and Breastfeeding Individuals in Clinical Trials"}]},{"@type":"WebSite","@id":"https:\/\/www.chemsafe-consulting.com\/it\/#website","url":"https:\/\/www.chemsafe-consulting.com\/it\/","name":"ChemSafe","description":"Your lighthouse in a sea of rules","publisher":{"@id":"https:\/\/www.chemsafe-consulting.com\/it\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.chemsafe-consulting.com\/it\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"it-IT"},{"@type":"Organization","@id":"https:\/\/www.chemsafe-consulting.com\/it\/#organization","name":"ChemSafe","url":"https:\/\/www.chemsafe-consulting.com\/it\/","logo":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/www.chemsafe-consulting.com\/it\/#\/schema\/logo\/image\/","url":"https:\/\/www.chemsafe-consulting.com\/wp-content\/uploads\/2023\/09\/logo-blu.png","contentUrl":"https:\/\/www.chemsafe-consulting.com\/wp-content\/uploads\/2023\/09\/logo-blu.png","width":170,"height":69,"caption":"ChemSafe"},"image":{"@id":"https:\/\/www.chemsafe-consulting.com\/it\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.linkedin.com\/company\/chemsafe-srl\/"]},{"@type":"Person","@id":"https:\/\/www.chemsafe-consulting.com\/it\/#\/schema\/person\/ef0ec20da44f19fd3ed5eb9334b54119","name":"Gabriele Pincitore","image":{"@type":"ImageObject","inLanguage":"it-IT","@id":"https:\/\/www.chemsafe-consulting.com\/it\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/fcfc5334bd73000515e017fd70f0559c45e85a8c514b7ebdccbfc77232c63d67?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/fcfc5334bd73000515e017fd70f0559c45e85a8c514b7ebdccbfc77232c63d67?s=96&d=mm&r=g","caption":"Gabriele Pincitore"},"url":"https:\/\/www.chemsafe-consulting.com\/it\/author\/chemsafe\/"}]}},"_links":{"self":[{"href":"https:\/\/www.chemsafe-consulting.com\/it\/wp-json\/wp\/v2\/posts\/26484","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.chemsafe-consulting.com\/it\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.chemsafe-consulting.com\/it\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.chemsafe-consulting.com\/it\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.chemsafe-consulting.com\/it\/wp-json\/wp\/v2\/comments?post=26484"}],"version-history":[{"count":3,"href":"https:\/\/www.chemsafe-consulting.com\/it\/wp-json\/wp\/v2\/posts\/26484\/revisions"}],"predecessor-version":[{"id":26488,"href":"https:\/\/www.chemsafe-consulting.com\/it\/wp-json\/wp\/v2\/posts\/26484\/revisions\/26488"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.chemsafe-consulting.com\/it\/wp-json\/wp\/v2\/media\/26485"}],"wp:attachment":[{"href":"https:\/\/www.chemsafe-consulting.com\/it\/wp-json\/wp\/v2\/media?parent=26484"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.chemsafe-consulting.com\/it\/wp-json\/wp\/v2\/categories?post=26484"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.chemsafe-consulting.com\/it\/wp-json\/wp\/v2\/tags?post=26484"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}